Dolphin Medical Services Share Price
6.00+0.00 (+0.00%)
+177.78% past 1 Year
Corporate filings & documents
Announcements
Intimation of Resignation of Mr GV MOHAN PRASAD Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA as directors of the company.
1 week agoIntimation of Resignation of Mr GV MOHAN PRASAD Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA as directors of the company.
1 week agoResignation of Mr GV MOHAN PRASAD Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA
1 week agoResignation of Mr GV MOHAN PRASAD Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA
1 week agoIntimation of Extension of AGM
2 weeks agoIntimation of Extension of AGM
2 weeks agoRarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post-Offer advertisement under Regulation 18(12) in terms of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended ("SEBI (SAST) Regulations") for the attention of the Equity Shareholders of Dolphin Medical Services Ltd ("Target Company").
3 weeks agoRarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post-Offer advertisement under Regulation 18(12) in terms of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended ("SEBI (SAST) Regulations") for the attention of the Equity Shareholders of Dolphin Medical Services Ltd ("Target Company").
3 weeks agoResults
1 month agoResults
1 month agoBoard meeting outcome
1 month agoBoard meeting outcome
1 month agoDolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Board Meeting Intimation for Board Meeting Is Scheduled To Be Held On Thursday August 14 2026 Inter Alia To Consider & Approve The Unaudited Standalone Financial Results Of The Company For The 1St Quarter Ended June 30 2026 Of The Financial Year 2026-27.
1 month agoDolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Board Meeting Intimation for Board Meeting Is Scheduled To Be Held On Thursday August 14 2026 Inter Alia To Consider & Approve The Unaudited Standalone Financial Results Of The Company For The 1St Quarter Ended June 30 2026 Of The Financial Year 2026-27.
1 month agoRarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer advertisement cum corrigendum to the Public Announcement and Detailed Public Statement under Regulation 18(7) in terms of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 in respect to the Open Offer of the Dolphin Medical Services Limited ("Target Company").
1 month agoRarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer advertisement cum corrigendum to the Public Announcement and Detailed Public Statement under Regulation 18(7) in terms of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 in respect to the Open Offer of the Dolphin Medical Services Limited ("Target Company").
1 month agoRarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (IDC) of Dolphin Medical Services Ltd (Target Company) in relation to the Open Offer (Offer) to the Public Shareholders of the Target Company under the provisions of Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 and Subsequent Amendments thereto (SEBI (SAST) Regulations).
1 month agoRarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (IDC) of Dolphin Medical Services Ltd (Target Company) in relation to the Open Offer (Offer) to the Public Shareholders of the Target Company under the provisions of Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 and Subsequent Amendments thereto (SEBI (SAST) Regulations).
1 month agoRarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer ("LOF") to the public shareholders of Dolphin Medical Services Ltd ("Target Company").
1 month agoRarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer ("LOF") to the public shareholders of Dolphin Medical Services Ltd ("Target Company").
1 month agoMs. Vaishnavi Sharma Chief Financial Officer of the Company has tendered resignation and the same is intimated herewith.
1 month agoMs. Vaishnavi Sharma Chief Financial Officer of the Company has tendered resignation and the same is intimated herewith.
1 month agoMs. Vaishnavi Sharma Company Secretary and Compliance officer of the Company has tendered resignation and the same is intimated herewith.
1 month agoMs. Vaishnavi Sharma Company Secretary and Compliance officer of the Company has tendered resignation and the same is intimated herewith.
1 month agoRarever Financial Advisors Pvt Ltd ("Manager to the Offer") has informed BSE regarding the identified date for the purpose of determining the names of the shareholders to whom the Letter of Offer would be sent is fixed as July 17 2026.<BR><BR>In compliance with regulation 18(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations 2011 the Identified Date is for the purpose of determining the names of the shareholders as on such date to whom the Letter of Offer would be sent.
2 months agoRarever Financial Advisors Pvt Ltd ("Manager to the Offer") has informed BSE regarding the identified date for the purpose of determining the names of the shareholders to whom the Letter of Offer would be sent is fixed as July 17 2026.<BR><BR>In compliance with regulation 18(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations 2011 the Identified Date is for the purpose of determining the names of the shareholders as on such date to whom the Letter of Offer would be sent.
2 months agocertificate under Reg 74(5) from RTA
2 months agocertificate under Reg 74(5) from RTA
2 months agoRarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Dolphin Medical Services Ltd ("Target Company").
3 months agoRarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Dolphin Medical Services Ltd ("Target Company").
3 months agoAnnual Compliance Report under Regulation 24A of SEBI (LODR) for financial year ended 31 march 2026.
3 months agoRarever Financial Advisors Pvt. Ltd ("Manager to the Offer") has submitted to BSE a copy of Corrigendum to the Detailed Public Statement for the attention of the Public Shareholders of Dolphin Medical Services Ltd ("Target Company").
4 months agoRarever Financial Advisors Private Limited (hereafter referred to as Manager to the Offer) are hereby submitting the Detailed Public Statement made by us on behalf of Mr. Amarandhar Reddy Kotha (Acquirer 1) and Mr. Mallour Rajesh Kumar (Acquirer 2) to acquire 39 25 988 equity shares representing 26% of the total paid-up equity shares of Target Company at a price of ? 4.80/- for each equity shares of Target Company pursuant to and in compliance with Regulation 4 of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 and subsequent amendments thereto.
4 months agoRarever Financial Advisors Private Limited (hereafter referred to as Manager to the Offer) are hereby submitting the Detailed Public Statement made by us on behalf of Mr. Amarandhar Reddy Kotha (Acquirer 1) and Mr. Mallour Rajesh Kumar (Acquirer 2) to acquire 39 25 988 equity shares representing 26% of the total paid-up equity shares of Target Company at a price of ? 4.80/- for each equity shares of Target Company pursuant to and in compliance with Regulation 4 of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 and subsequent amendments thereto.
4 months agoRarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 4 read with Regulations 13(4) 14(3) and 15(2) and other applicable regulations of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 and subsequent amendments thereof for the attention of the public shareholders of Dolphin Medical Services Ltd ("Target Company").
4 months agoRegulation 74(5)
4 months agoResults
4 months agoResults
4 months agoBoard Meeting outcome
4 months agoBoard Meeting outcome
4 months agoRarever Financial Advisors Private Limited (hereafter referred to as "Manager to the Offer") are herby submitting the Public Announcement made by us on behalf of Mr Amarandhar Reddy Kotha (Acquirer- 1) and Mr Mallour Rajesh Kumar ( Acquirer-2) to acquire 39 25 988 equity shares representing 26% of the total paid-up capital equity shares of Target Company at a price of Rs 4.80/- for each equity share of the Target Company pursuant to and in compliance with regulation 9 of SEBI(SAST) Regulations 2011 and subsequent amendment
4 months agoOpen Offer - Public Announcement
4 months agoDolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 inter alia to consider and approve Board meeting intimation
4 months agoDolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 inter alia to consider and approve Board meeting intimation
4 months agoBoard meeting outcome
5 months agoBoard meeting outcome
5 months agoBoard meeting outcome
5 months agoBoard meeting outcome
5 months agoDolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/04/2026 inter alia to consider and approve Board meeting intimation
5 months agoCorrigendum to the Board meeting outcome
5 months agoAnnual reports
Concalls & investor presentations
No presentations found